8-K - Quince Therapeutics, Inc. (0001662774) (Filer)
Published . Updated .
Filed: 2026-10-09 AccNo: 0001193125-26-418538 Size: 476 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Directly affected
- QNCX QUINCE THERAPEUTICS INC COM PA
SEC 8-K filing -> direct issuer disclosure -> QNCX
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-09 AccNo: 0001193125-26-418538 Size: 476 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments t…
Source: sec-edgar
Quince Therapeutics (QNCX) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| GLD | that day | +1.57% | final price |
| GLD | the next day | +0.93% | final price |
| GLD | two days later | +0.80% | final price |
| GLD | three days later | -0.70% | final price |
| GLD | three days earlier | +0.96% | final price |
| GLD | five days earlier | +0.41% | final price |
| Quince Therapeutics (QNCX) | that day | +8.07% | final price |
| Quince Therapeutics (QNCX) | the next day | +10.35% | final price |
| Quince Therapeutics (QNCX) | two days later | -5.07% | final price |
| Quince Therapeutics (QNCX) | three days later | +2.18% | final price |
| Quince Therapeutics (QNCX) | three days earlier | -8.69% | final price |
| Quince Therapeutics (QNCX) | five days earlier | -0.54% | final price |
| QQQ | that day | +0.50% | final price |
| QQQ | the next day | -0.20% | final price |
| QQQ | two days later | -0.52% | final price |
| QQQ | three days later | -2.48% | final price |
| QQQ | three days earlier | +1.62% | final price |
| QQQ | five days earlier | +0.27% | final price |
| SPY | that day | +0.60% | final price |
| SPY | the next day | +0.54% | final price |
| SPY | two days later | +0.54% | final price |
| SPY | three days later | -0.55% | final price |
| SPY | three days earlier | +0.67% | final price |
| SPY | five days earlier | -0.55% | final price |
| TLT | that day | +0.12% | final price |
| TLT | the next day | +0.21% | final price |
| TLT | two days later | +0.62% | final price |
| TLT | three days later | +1.30% | final price |
| TLT | three days earlier | -0.76% | final price |
| TLT | five days earlier | -0.49% | final price |
Who is named in “8-K - Quince Therapeutics, Inc. (0001662774) (Filer)”
Companies mentioned with this story
- QNCX Quince Therapeutics
Quince Therapeutics (QNCX) is linked, with no stored direction, high confidence in the 9 Oct 2026 story “8-K - Quince Therapeutics, Inc. (0001662774) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> QNCX
How “8-K - Quince Therapeutics, Inc. (0001662774) (Filer)” reaches Quince Therapeutics (QNCX)
The 9 Oct 2026 story “8-K - Quince Therapeutics, Inc. (0001662774) (Filer)” names Quince Therapeutics (QNCX) because of this story.
For Quince Therapeutics (QNCX), the reason on file says SEC 8-K filing -> direct issuer disclosure -> QNCX
Price levels for Quince Therapeutics (QNCX)
QNCX traded between 26.23 and 36.26 across 12 sessions. The latest close on file is 31.30.
What the saved facts support for Quince Therapeutics (QNCX)
44 out of 100
“8-K - Quince Therapeutics, Inc. (0001662774) (Filer)” scores 44 out of 100. The score uses 1 sources, a +9.81% difference versus the S&P 500 (SPY), and 1 linked companies.